NHS Health Check

Last updated

The NHS Health Check is a preventive healthcare programme offered by Public Health England. The programme invites adults aged between 40 and 74 in England for a health check-up every five years to screen for key conditions including heart disease, diabetes, kidney disease, and stroke. [1] Local authorities are responsible for the commissioning of the programme, with GPs being the most common provider, followed by community outreach and pharmacy providers. [2]

Contents

Creation and criticism

In January 2008, UK Prime Minister Gordon Brown announced that preventive healthcare was planned to be offered throughout England to "monitor for heart disease, strokes, diabetes and kidney disease–conditions which affect the lives of 6.2 million people, cause 200,000 deaths each year and account for a fifth of all hospital admissions." [3]

Some, such as the Glasgow GP Margaret McCartney, have criticised the programme of health checks as being without evidence of effectiveness. [4] However, the head of health and wellbeing at Public Health England Kevin Fenton defended the programme, claiming it was evidence-based. [5]

A study published in 2014 in the British Journal of General Practice found no significant differences in the change to the prevalence of diabetes, hypertension, heart disease, chronic kidney disease or atrial fibrillation in general practices providing NHS Health Checks compared with control practices. [6]

On 22 May, 2023, the Labour leader, Sir Keir Starmer, presented a plan to bring the National Health Service (NHS) “back on its feet” in the event that his party wins the general election. Starmer pledged to reduce deaths from heart diseases, cancer, and suicide in England. He made a commitment to reduce heart diseases and strokes by 25% over the next 10 years, along with reducing A&E waiting times and lowering suicide rates over the next five years. [7]

Costs and take-up

Peter Walsh, deputy director of the Strategy Group at NHS England admitted that take-up of the checks was poor in January 2016, after a study showed that 20% of those eligible aged 60–74 attended and 9.0% of those between 40 and 59. [8]

In May 2016 researchers from Imperial College London concluded that the checkup reduced the 10-year risk of cardiovascular disease by 0.21%, equivalent to one stroke or heart attack avoided every year for 4,762 people who attend. The programme cost £165 million a year. [9]

A retrospective observational study by the Centre for Primary Care and Public Health, Queen Mary University of London found that take up in an ethnically diverse and socially deprived area of East London had increased from 7.3% of eligible patients in 2009 to 85.0% in 2013–2014. New diagnoses of diabetes were 30% more likely in attendees than nonattendees, hypertension 50%, and Chronic Kidney Disease 80%. [10]

In August 2019, Matt Hancock announced that the checks would be more tailored to individuals’ risks. [11]

In the five years from 2016 to 2021, the average uptake of an NHS Health Check following an invite was 46.5%. [12] In the same period, there were stark inequalities in uptake between the regions of England, particularly in areas of London, the North West, and the West Midlands. [13]

Elsewhere in the UK

Scotland

In Scotland, the Keep Well programme was introduced in October 2006 to screen for cardiovascular diseases and associated risk factors, [14] with a focus on reducing health inequalities. [15] Those over 40 years old were invited for a Keep Well check at least every five years. [14] The programme operated in several waves, each with updated requirements and specifications, [15] and its effectiveness was judged to be mixed. [14] In December 2013, the Scottish Chief Medical Officer announced the Government would discontinue funding for the Keep Well programme. The programme subsequently ended in March 2017. [15] [16]

See also

Related Research Articles

Antihypertensives are a class of drugs that are used to treat hypertension. Antihypertensive therapy seeks to prevent the complications of high blood pressure, such as stroke, heart failure, kidney failure and myocardial infarction. Evidence suggests that reduction of the blood pressure by 5 mmHg can decrease the risk of stroke by 34% and of ischaemic heart disease by 21%, and can reduce the likelihood of dementia, heart failure, and mortality from cardiovascular disease. There are many classes of antihypertensives, which lower blood pressure by different means. Among the most important and most widely used medications are thiazide diuretics, calcium channel blockers, ACE inhibitors, angiotensin II receptor antagonists (ARBs), and beta blockers.

<span class="mw-page-title-main">Chronic kidney disease</span> Medical condition

Chronic kidney disease (CKD) is a type of kidney disease in which a gradual loss of kidney function occurs over a period of months to years. Initially generally no symptoms are seen, but later symptoms may include leg swelling, feeling tired, vomiting, loss of appetite, and confusion. Complications can relate to hormonal dysfunction of the kidneys and include high blood pressure, bone disease, and anemia. Additionally CKD patients have markedly increased cardiovascular complications with increased risks of death and hospitalization.

<span class="mw-page-title-main">Preventive healthcare</span> Prevent and minimize the occurrence of diseases

Preventive healthcare, or prophylaxis is the application of healthcare measures to prevent diseases. Disease and disability are affected by environmental factors, genetic predisposition, disease agents, and lifestyle choices, and are dynamic processes which begin before individuals realize they are affected. Disease prevention relies on anticipatory actions that can be categorized as primal, primary, secondary, and tertiary prevention.

A chronic condition is a health condition or disease that is persistent or otherwise long-lasting in its effects or a disease that comes with time. The term chronic is often applied when the course of the disease lasts for more than three months. Common chronic diseases include diabetes, functional gastrointestinal disorder, eczema, arthritis, asthma, chronic obstructive pulmonary disease, autoimmune diseases, genetic disorders and some viral diseases such as hepatitis C and acquired immunodeficiency syndrome. An illness which is lifelong because it ends in death is a terminal illness. It is possible and not unexpected for an illness to change in definition from terminal to chronic. Diabetes and HIV for example were once terminal yet are now considered chronic due to the availability of insulin for diabetics and daily drug treatment for individuals with HIV which allow these individuals to live while managing symptoms.

<span class="mw-page-title-main">NHS Scotland</span> Publicly-funded healthcare system in Scotland

NHS Scotland, sometimes styled NHSScotland, is the publicly funded healthcare system in Scotland and one of the four systems that make up the National Health Service in the United Kingdom. It operates 14 territorial NHS boards across Scotland, supported by seven special non-geographic health boards, and Public Health Scotland.

<span class="mw-page-title-main">Perindopril</span> High blood pressure medication

Perindopril is a medication used to treat high blood pressure, heart failure, or stable coronary artery disease.

The Quality and Outcomes Framework (QOF) is a system for the performance management and payment of general practitioners (GPs) in the National Health Service (NHS) in England, Wales, Scotland and Northern Ireland. It was introduced as part of a new general medical services (GMS) contract in April 2004, replacing various other fee arrangements.

A National Service Framework (NSF) was any of several policies set by the National Health Service (NHS) in England to define standards of care for major medical issues such as cancer, coronary heart disease, chronic obstructive pulmonary disease, diabetes, kidney disease, long-term conditions, mental health, old age, and stroke care.

<span class="mw-page-title-main">Non-communicable disease</span> Medical condition

A non-communicable disease (NCD) is a disease that is not transmissible directly from one person to another. NCDs include Parkinson's disease, autoimmune diseases, strokes, most heart diseases, most cancers, diabetes, chronic kidney disease, osteoarthritis, osteoporosis, Alzheimer's disease, cataracts, and others. NCDs may be chronic or acute. Most are non-infectious, although there are some non-communicable infectious diseases, such as parasitic diseases in which the parasite's life cycle does not include direct host-to-host transmission.

<span class="mw-page-title-main">University Hospitals of Leicester NHS Trust</span> NHS hospital trust


University Hospitals of Leicester NHS Trust was created in April 2000 with the merger of the Leicester General Hospital, Glenfield Hospital and Leicester Royal Infirmary.

<span class="mw-page-title-main">Dapagliflozin</span> Diabetes medication

Dapagliflozin, sold under the brand names Farxiga (US) and Forxiga (EU) among others, is a medication used to treat type 2 diabetes. It is also used to treat adults with heart failure and chronic kidney disease.

Unwarranted variation in health care service delivery refers to medical practice pattern variation that cannot be explained by illness, medical need, or the dictates of evidence-based medicine. It is one of the causes of low value care often ignored by health systems.

Health in the United Kingdom refers to the overall health of the population of the United Kingdom. This includes overall trends such as life expectancy and mortality rates, mental health of the population and the suicide rate, smoking rates, alcohol consumption, prevalence of diseases within the population and obesity in the United Kingdom. Three of these, smoking rates, alcohol consumption and obesity are above the OECD average.

Health in England refers to the overall health of the population of England. Despite overall increases in life expectancy in England, the most deprived areas continue to see no change or a decrease in life expectancy. The Blair Government instituted a comprehensive programme to reduce health inequalities in England between 1997 and 2010 focused on reducing geographical inequalities in life expectancy. It was targeted at the Spearhead areas - the 20% of local authorities with the worst health and deprivation indicators. This led to more NHS resources being directed to the most deprived areas. The strategy was associated with a decline in geographical inequalities in life expectancy, reversing a trend which had increased over a long period. However, health inequalities still remain. In 2014 to 2016, the difference in life expectancy between the most and least deprived areas of England was 9.3 years for males and 7.3 years for females.

The Healthcare Quality Improvement Partnership (HQIP) was established in April 2008 to promote improvement in health services, by increasing the impact that clinical audit has on healthcare quality in England and Wales and, in some cases other devolved nations. It is led by a consortium of the Academy of Medical Royal Colleges, Royal College of Nursing and National Voices.

<span class="mw-page-title-main">Eastern Health Alliance</span> Hospital in Tampines Plaza, Singapore

Eastern Health Alliance was a regional health system in the east of Singapore.

<span class="mw-page-title-main">Epidemiology of diabetes</span>

Globally, an estimated 537 million adults are living with diabetes, according to 2019 data from the International Diabetes Federation. Diabetes was the 9th-leading cause of mortality globally in 2020, attributing to over 2 million deaths annually due to diabetes directly, and to kidney disease due to diabetes. The primary causes of type 2 diabetes is diet and physical activity, which can contribute to increased BMI, poor nutrition, hypertension, alcohol use and smoking, while genetics is also a factor. Diabetes prevalence is increasing rapidly; previous 2019 estimates put the number at 463 million people living with diabetes, with the distributions being equal between both sexes icidence peaking around age 55 years old. The number is projected to 643 million by 2030, or 7079 individuals per 100,000, with all regions around the world continue to rise. Type 2 diabetes makes up about 85-90% of all cases. Increases in the overall diabetes prevalence rates largely reflect an increase in risk factors for type 2, notably greater longevity and being overweight or obese. The prevalence of African Americans with diabetes is estimated to triple by 2050, while the prevalence of whites is estimated to double. The overall prevalence increases with age, with the largest increase in people over 65 years of age. The prevalence of diabetes in America is estimated to increase to 48.3 million by 2050.

<span class="mw-page-title-main">Finerenone</span> Chemical compound

Finerenone, sold under the brand name Kerendia, is a medication used to reduce the risk of kidney function decline, kidney failure, cardiovascular death, non-fatal heart attacks, and hospitalization for heart failure in adults with chronic kidney disease associated with type 2 diabetes. Finerenone is a non-steroidal mineralocorticoid receptor antagonist (MRA). It is taken orally.

A renal diet is a diet aimed at keeping levels of fluids, electrolytes, and minerals balanced in the body in individuals with chronic kidney disease or who are on dialysis. Dietary changes may include the restriction of fluid intake, protein, and electrolytes including sodium, phosphorus, and potassium. Calories may also be supplemented if the individual is losing weight undesirably.

<span class="mw-page-title-main">Diabetes in India</span>

India has an estimated 77 million people formally diagnosed with diabetes, which makes it the second most affected in the world, after China. Furthermore, 700,000 Indians died of diabetes, hyperglycemia, kidney disease or other complications of diabetes in 2020. One in six people (17%) in the world with diabetes is from India. The number is projected to grow by 2045 to become 134 million per the International Diabetes Federation.

References

  1. "What is an NHS Health Check?". nhs.uk. 21 December 2017. Retrieved 13 August 2021.
  2. "Findings from the 2019/20 NHS Health Check Delivery Survey". NHS Health Check. Public Health England. March 2021. Retrieved 14 August 2021.
  3. "In full: Brown speech on the NHS". BBC News. 7 January 2008. Retrieved 11 November 2013.
  4. "Too Much Medicine Where's the evidence for NHS health checks?". British Medical Journal. 2 October 2013. Retrieved 11 November 2013.
  5. "NHS Health Checks programme 'evidence based', public health chief insists". Pulse. 17 September 2014. Retrieved 18 September 2014.
  6. Caley, Michael; Chohan, Paradip; Hooper, James; Wright, Nicola (1 August 2014). "The impact of NHS Health Checks on the prevalence of disease in general practices: a controlled study". Vol. 64, no. 625. British Journal of General Practice. Retrieved 18 September 2014.
  7. Hourigan, Tom (22 June 2023). "Keir Starmer to promise Labour would reduce deaths from heart disease, strokes and suicide". Nationalworld. Retrieved 21 June 2023.
  8. "Take up of health checks are "not strong, to put it mildly"". Nursing in practice. 15 January 2016. Retrieved 6 April 2016.
  9. "NHS "mid-life MOT" has marginal health benefits, say researchers". Imperial College. 3 May 2016. Retrieved 3 May 2016.
  10. Robson, John; Dostal, Isabel; Madurasinghe, Vichithranie; Sheikh, Aziz; Hull, Sally; Boomla, Kambiz; Griffiths, Chris; Eldridge, Sandra (2016). "NHS Health Check comorbidity and management: an observational matched study in primary care". British Journal of General Practice. 67 (Online first): e86–e93. doi:10.3399/bjgp16X688837. PMC   5308122 . PMID   27993901.
  11. "Patients attending Health Checks since 2012 increases by over half". Management in Practice. 18 October 2019. Retrieved 24 November 2019.
  12. "NHS Health Check: People taking up an NHS Health Check Invite". Fintertips. Public Health England. Retrieved 14 August 2021.
  13. "NHS Health Check: People taking up an NHS Health Check (map)". Fingertips. Public Health England. Retrieved 14 August 2021.
  14. 1 2 3 Geue, Claudia; Lewsey, James D.; MacKay, Daniel F.; Antony, Grace; Fischbacher, Colin M.; Muirie, Jill; McCartney, Gerard (1 September 2016). "Scottish Keep Well health check programme: an interrupted time series analysis". J Epidemiol Community Health. 70 (9): 924–929. doi:10.1136/jech-2015-206926. ISSN   0143-005X. PMC   5013158 . PMID   27072868.
  15. 1 2 3 "The impact of Keep Well: An evaluation of the Keep Well programme from 2006 to 2012" (PDF). NHS Health Scotland. 2014. Retrieved 14 August 2021.
  16. "Greater Glasgow and Clyde NHS Board, Board Meeting: Keep Well and Chronic Disease Management Programme Update" (PDF). NHS Greater Glasgow and Clyde Board. Retrieved 14 August 2021.